Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,599.90
3,591.52
3,771.67
3,999.02
3,638.38
3,601.27
3,497.95
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,599.90
3,591.52
3,771.67
3,999.02
3,638.38
3,601.27
3,497.95
Raw Material Cost
1,893.33
1,979.44
2,079.52
2,318.15
2,064.36
2,063.69
1,949.85
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
483.26
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
5.72
8.47
5.96
6.43
5.83
2.92
1.19
Selling and Distribution Expenses
1,156.15
1,119.01
1,161.11
1,157.04
1,106.62
1,089.27
1,104.13
Other Expenses
17.28
20.42
13.53
10.07
9.51
9.18
-38.84
Total Expenditure (Excl Depreciation)
3,228.01
3,311.08
3,381.92
3,582.28
3,271.95
3,247.68
3,150.02
Operating Profit (PBDIT) excl Other Income
371.9
280.4
389.79999999999995
416.70000000000005
366.4
353.6
347.9
Other Income
66.63
61.34
83.96
52.37
77.26
79.63
102.09
Operating Profit (PBDIT)
549.97
462.78
582.14
569.58
534.80
497.54
509.59
Interest
5.72
8.47
5.96
6.43
5.83
2.92
1.19
Exceptional Items
3.16
3.61
-1.60
-1.30
6.27
6.74
-8.22
Gross Profit (PBDT)
1,706.56
1,612.08
1,692.15
1,680.88
1,574.02
1,537.58
1,548.10
Depreciation
124.04
120.55
122.19
112.40
102.16
76.77
70.49
Profit Before Tax
423.37
337.37
452.40
449.45
433.09
424.58
429.70
Tax
59.43
32.70
65.40
58.67
58.68
64.38
77.60
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
286.29
230.76
320.41
302.51
302.06
297.07
294.31
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
286.29
230.76
320.41
302.51
302.06
297.07
294.31
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
89.38
71.85
74.61
84.64
72.68
63.14
57.79
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
375.67
302.61
395.02
387.15
374.74
360.21
352.10
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,028.30
2,462.28
2,389.67
2,216.98
2,150.39
2,266.77
2,178.08
Earnings per share (EPS)
0.66
0.55
0.77
0.72
0.72
0.71
0.7
Diluted Earnings per share
0.66
0.55
0.77
0.72
0.72
0.71
0.7
Operating Profit Margin (Excl OI)
9.98%
7.82%
9.97%
10.12%
9.77%
9.47%
9.63%
Gross Profit Margin
15.21%
12.75%
15.23%
14.05%
14.71%
13.92%
14.3%
PAT Margin
7.95%
6.43%
8.5%
7.56%
8.3%
8.25%
8.41%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 0.23% vs -4.78% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 24.16% vs -23.39% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 20.40% vs -19.43% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -32.94% vs 41.67% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Zhuzhou Qianjin Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
3,599.90
0
3,599.90
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,599.90
0
3,599.90
Raw Material Cost
1,893.33
0
1,893.33
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
5.72
0
5.72
Selling and Distribution Expenses
1,156.15
0
1,156.15
Other Expenses
17.28
0.00
17.28
Total Expenditure (Excl Depreciation)
3,228.01
0
3,228.01
Operating Profit (PBDIT) excl Other Income
371.89
0.00
371.89
Other Income
66.63
0
66.63
Operating Profit (PBDIT)
549.97
0
549.97
Interest
5.72
0
5.72
Exceptional Items
3.16
0
3.16
Gross Profit (PBDT)
1,706.56
0
1,706.56
Depreciation
124.04
0
124.04
Profit Before Tax
423.37
0
423.37
Tax
59.43
0
59.43
Provisions and contingencies
0
0
0.00
Profit After Tax
286.29
0
286.29
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
286.29
0
286.29
Share in Profit of Associates
0
0
0.00
Minority Interest
89.38
0
89.38
Other related items
0.00
0.00
0.00
Consolidated Net Profit
375.67
0
375.67
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,028.30
0
3,028.30
Earnings per share (EPS)
0.66
0
0.66
Diluted Earnings per share
0.66
0
0.66
Operating Profit Margin (Excl OI)
9.98%
0%
0.00
9.98%
Gross Profit Margin
15.21%
0%
0.00
15.21%
PAT Margin
7.95%
0%
0.00
7.95%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 359.99 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 0.23% vs -4.78% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 37.57 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 24.16% vs -23.39% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 48.33 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 20.40% vs -19.43% in Dec 2024
Annual - Interest
Interest 0.57 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -32.94% vs 41.67% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.98%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






